Loading...

NXTC NEXTCURE INC US FDA Inspections 8-K Filing

NXTC

NXTC

NEXTCURE INC

(NXTC)

2024 8-K

Show Summary

Show Summary

Licensing Agreement

Earnings Releases

Corporate Update

Financial Results

New Treatment Study

Drug Application Filed

Financial Results

Earnings Reports

Annual Meeting Results

Retirement and Consulting A...

Financial Results Announcement

Regulation FD Disclosure

Earnings Reports

Financial Results Announcement

Amended Bylaws Approval

Earnings Reports

Earnings Reports

External Links:

NextCure, Inc. announced that it has filed an Investigational New Drug Application for its product candidate LNCB74 and will engage with the investment community using updated presentation materials.

AI Assistant

NEXTCURE INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.